Contact us todayContact us today

Artificial Intelligence (AI) in Drug Development and Regulatory Decisionmaking

Artificial Intelligence (AI) in Drug Development and Regulatory Decisionmaking

Last Updated: January 10, 2025By Dr. Kishore HothaCategories: Publications

FDA Guidance on AI in Drug and Biological Product Regulatory Decision

Related projects

View all projects

Is Your CDMO Using These Aidriven Solutions in CMC For Oliogs and Peptides?

Rethinking Nitrosamines – Moving Beyond Compliance

Where Biotech Wins: “The Role of CMC Excellence”

Operational Excellence Tools in Pharma & Biotech for Driving Efficiency

CMC Strategies With CDMOs: Ensuring CQAs For Oligos And Peptides

Mastering ADC’s Development

Let’s Make Things Happen

Contact Info

Dr. Hotha’s Life Sciences LLC
30 Longview Circle,
Ayer, MA 01432, USA
contact@drhothas.com
+1-978-501-4938

Dr. Kishore Hotha, PhD, MBA – President, Dr. Hotha Life Sciences LLC

Connect Dr. HothaConnect Dr. Hotha